Türkiye plans to begin mass production of its domestically developed LIFELINE HLM heart-lung machine by the end of 2026 after the device entered clinical use.

Turkey’s dietary supplements market is expected to continue expanding, driven by growing consumer interest in health and nutrition products. Market…

Reports that AstraZeneca has held discussions over a potential merger with Bristol Myers Squibb triggered a sharp market reaction, with…

Siemens Healthineers and Ohio-based University Hospitals have signed a 10-year strategic Value Partnership to expand access to advanced imaging, cancer care, and digital health technologies. The agreement builds on nearly four decades of collaboration and aims to accelerate innovation in patient care and clinical research.

Türkiye’s dietary supplements market grew by 56.7% year over year to TL 29.9 billion in 2025, according to IQVIA, with magnesium, vitamin D, iron, and omega-3 products driving much of the market’s expansion.

Turkish residents spent TL 10.6 billion on domestic travel for healthcare purposes during the first quarter of the year, according to the Turkish Statistical Institute (TurkStat), as total domestic travel expenditure exceeded TL 102.3 billion.

Turkish Health Minister Kemal Memişoğlu said the country’s growing domestic medical technology sector has enabled Türkiye to export mechanical ventilators to 40 countries, highlighting continued investment in local manufacturing and health innovation.

Johnson & Johnson has proposed a $5.5 billion settlement to resolve nearly all remaining U.S. lawsuits alleging its talc-based baby powder and other products caused ovarian cancer, while continuing to deny the claims.

Turkish Health Minister Kemal Memişoğlu said Türkiye aims to generate $50 billion in health exports within the next 10 years,…